Mucolipidosis type IV

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Mucolipidosis type IV
Classification and external resources
ICD-10 E75.1
OMIM 252650
DiseasesDB 32693
MeSH C05.116.198.371

WikiDoc Resources for

Mucolipidosis type IV

Articles

Most recent articles on Mucolipidosis type IV

Most cited articles on Mucolipidosis type IV

Review articles on Mucolipidosis type IV

Articles on Mucolipidosis type IV in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mucolipidosis type IV

Images of Mucolipidosis type IV

Photos of Mucolipidosis type IV

Podcasts & MP3s on Mucolipidosis type IV

Videos on Mucolipidosis type IV

Evidence Based Medicine

Cochrane Collaboration on Mucolipidosis type IV

Bandolier on Mucolipidosis type IV

TRIP on Mucolipidosis type IV

Clinical Trials

Ongoing Trials on Mucolipidosis type IV at Clinical Trials.gov

Trial results on Mucolipidosis type IV

Clinical Trials on Mucolipidosis type IV at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mucolipidosis type IV

NICE Guidance on Mucolipidosis type IV

NHS PRODIGY Guidance

FDA on Mucolipidosis type IV

CDC on Mucolipidosis type IV

Books

Books on Mucolipidosis type IV

News

Mucolipidosis type IV in the news

Be alerted to news on Mucolipidosis type IV

News trends on Mucolipidosis type IV

Commentary

Blogs on Mucolipidosis type IV

Definitions

Definitions of Mucolipidosis type IV

Patient Resources / Community

Patient resources on Mucolipidosis type IV

Discussion groups on Mucolipidosis type IV

Patient Handouts on Mucolipidosis type IV

Directions to Hospitals Treating Mucolipidosis type IV

Risk calculators and risk factors for Mucolipidosis type IV

Healthcare Provider Resources

Symptoms of Mucolipidosis type IV

Causes & Risk Factors for Mucolipidosis type IV

Diagnostic studies for Mucolipidosis type IV

Treatment of Mucolipidosis type IV

Continuing Medical Education (CME)

CME Programs on Mucolipidosis type IV

International

Mucolipidosis type IV en Espanol

Mucolipidosis type IV en Francais

Businness

Mucolipidosis type IV in the Marketplace

Patents on Mucolipidosis type IV

Experimental / Informatics

List of terms related to Mucolipidosis type IV

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mucolipidosis type IV (ML IV), like other types of mucolipidosis is an inherited neurodegenerative lysosomal storage disorder. Patients with this autosomal recessive disorder have symptoms including delayed psychomotor development and various ocular aberrations. This type of mucolipidosis is caused by mutation of a non-selective cation channel, TRPML1. These mutations disrupt lysosomal storage and lead to neurodegeneration through an unknown mechanism.

Symptoms and Signs

Most patients with ML IV show psychomotor retardation (i.e., delayed development of movement and coordination), corneal opacity, retinal degeneration and other ophthalmological abnormalities. Other symptoms include agenesis of the corpus callosum, iron deficiency, and improper stomache pH (achlorohydria). Achlorhydria in these patients results in an increase in blood gastrin levels. These symptoms typically manifest early in life (within the first year) and progress slowly.

Pathophysiology

ML IV is caused by mutations in the cation channel TRPML1 (Mucolipin-1). TRPML1 is localized in endosomes and may function as either a proton leak channel and/or aid in the regulation of calcium levels. An important property of TRPML1 is that decreasing pH (acidification) results in deactivation of the protein, likely through an assembly defect. There are 10 mutations in TRPML1, located throughout the channel. Three of these mutations (Q79X, R102X and R172X) result in early truncation of the channels and the loss of functional protein. The other seven mutations result in either amino acid substitution or deletion. Of these, V446I and ΔF408 are known to be functional as channels. In these mutants, however, there is no acidification induced defect in assembly. These alterations result in the blockage of endocytic transport and prevention of lysosome formation. Over-acidification of these organelles may result in decreased lipase activity. This decreased lipase activity might then result in the increased levels of lipids and membraneous materials seen in patients. Alternatively, build-up of intra-compartmental calcium may prevent the fusion processes in these organelles.

Treatment/Management

See the equivalent section in the main mucolipidosis article.

Epidemiology

Ashkenazi Jews have a high carrier frequency of 1:90 to 1:100.

References

fr:Mucolipidose type 4
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools